According to Actinium Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -HK$0.37 B. In 2023 the company made an earning of -HK$0.41 B a decrease over its 2022 earnings that were of -HK$0.27 B.The earnings displayed on this page is the company's Pretax Income.